A pharmaceutical company was facing a sophisticated “short and distort” stock market manipulation campaign, costing the company billions in market cap.   A variety of virtual anonymous personas were publishing false information on the company’s leadership on social media and investing platforms - apparently in a coordinated fashion. These activities negatively influenced public perception about the company’s overall corporate governance and  damaged the stock price thereby allowing those holding short positions to profit.